E. Baekkevold, M. Roussigné, T. Yamanaka, F. Johansen, F. Jahnsen et al., Molecular Characterization of NF-HEV, a Nuclear Factor Preferentially Expressed in Human High Endothelial Venules, The American Journal of Pathology, vol.163, issue.1, pp.69-79, 2003.
DOI : 10.1016/S0002-9440(10)63631-0

J. Schmitz, A. Owyang, E. Oldham, Y. Song, E. Murphy et al., IL-33, an Interleukin-1-like Cytokine that Signals via the IL-1 Receptor-Related Protein ST2 and Induces T Helper Type 2-Associated Cytokines, Immunity, vol.23, issue.5, pp.479-490, 2005.
DOI : 10.1016/j.immuni.2005.09.015

A. Mirchandani, R. Salmond, and F. Liew, Interleukin-33 and the function of innate lymphoid cells, Trends in Immunology, vol.33, issue.8, pp.389-396, 2012.
DOI : 10.1016/j.it.2012.04.005

F. Liew, N. Pitman, and I. Mcinnes, Disease-associated functions of IL-33: the new kid in the IL-1 family, Nature Reviews Immunology, vol.173, issue.2, pp.103-110, 2010.
DOI : 10.1038/nri2692

K. Oboki, T. Ohno, N. Kajiwara, H. Saito, and S. Nakae, IL-33 and IL-33 Receptors in Host Defense and Diseases, Allergology International, vol.59, issue.2, pp.143-160, 2010.
DOI : 10.2332/allergolint.10-RAI-0186

G. Palmer, D. Talabot-ayer, C. Lamacchia, D. Toy, C. Seemayer et al., Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis, Arthritis & Rheumatism, vol.5, issue.3, pp.738-749, 2009.
DOI : 10.1002/art.24305

D. Xu, H. Jiang, P. Kewin, Y. Li, R. Mu et al., IL-33 exacerbates antigen-induced arthritis by activating mast cells, Proceedings of the National Academy of Sciences, vol.105, issue.31, pp.10913-10918, 2008.
DOI : 10.1073/pnas.0801898105

C. Beltrán, L. Núñez, D. Díaz-jiménez, N. Farfan, E. Candia et al., Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease, Inflammatory Bowel Diseases, vol.16, issue.7, pp.1097-1107, 2010.
DOI : 10.1002/ibd.21175

Y. Kim, T. Yang, C. Park, S. Ahn, B. Son et al., Anti-IL-33 antibody has a therapeutic effect in a murine model of allergic rhinitis, Allergy, vol.5, issue.2, pp.183-190, 2012.
DOI : 10.1111/j.1398-9995.2011.02735.x

M. Kurowska-stolarska, P. Kewin, G. Murphy, R. Russo, B. Stolarski et al., IL-33 Induces Antigen-Specific IL-5+ T Cells and Promotes Allergic-Induced Airway Inflammation Independent of IL-4, The Journal of Immunology, vol.181, issue.7, pp.4780-4790, 2008.
DOI : 10.4049/jimmunol.181.7.4780

A. Miller, D. Xu, D. Asquith, L. Denby, Y. Li et al., IL-33 reduces the development of atherosclerosis, The Journal of Experimental Medicine, vol.209, issue.2, pp.339-346, 2008.
DOI : 10.1006/mthe.2001.0424

A. Miller and F. Liew, The IL-33/ST2 pathway ??? A new therapeutic target in cardiovascular disease, Pharmacology & Therapeutics, vol.131, issue.2, pp.179-186, 2011.
DOI : 10.1016/j.pharmthera.2011.02.005

J. Alves-filho, F. Sônego, F. Souto, A. Freitas, W. Verri et al., Interleukin-33 attenuates sepsis by enhancing neutrophil influx to the site of infection, Nature Medicine, vol.31, issue.6, pp.708-712, 2010.
DOI : 10.1038/nm.2156

L. Hazlett, S. Mcclellan, R. Barrett, X. Huang, Y. Zhang et al., Keratitis, Investigative Opthalmology & Visual Science, vol.51, issue.3, pp.1524-1532, 2010.
DOI : 10.1167/iovs.09-3983

N. Humphreys, D. Xu, M. Hepworth, F. Liew, and R. Grencis, IL-33, a Potent Inducer of Adaptive Immunity to Intestinal Nematodes, The Journal of Immunology, vol.180, issue.4, pp.2443-2449, 2008.
DOI : 10.4049/jimmunol.180.4.2443

M. Townsend, P. Fallon, D. Matthews, H. Jolin, and A. Mckenzie, T1/St2-Deficient Mice Demonstrate the Importance of T1/St2 in Developing Primary T Helper Cell Type 2 Responses, The Journal of Experimental Medicine, vol.151, issue.6, pp.1069-1076, 2000.
DOI : 10.1074/jbc.271.10.5784

P. Kropf, Q. Bickle, S. Herath, R. Klemenz, and I. Müller, Organ-specific distribution of CD4+ T1/ST2+ Th2 cells in Leishmania major infection, European Journal of Immunology, vol.32, issue.9, pp.2450-2459, 2002.
DOI : 10.1002/1521-4141(200209)32:9<2450::AID-IMMU2450>3.0.CO;2-O

P. Kropf, S. Herath, R. Klemenz, and I. Müller, Signaling through the T1/ST2 Molecule Is Not Necessary for Th2 Differentiation but Is Important for the Regulation of Type 1 Responses in Nonhealing Leishmaniamajor Infection, Infection and Immunity, vol.71, issue.4, pp.1961-1971, 2003.
DOI : 10.1128/IAI.71.4.1961-1971.2003

H. Murray, Mononuclear Cell Recruitment, Granuloma Assembly, and Response to Treatment in Experimental Visceral Leishmaniasis: Intracellular Adhesion Molecule 1-Dependent and -Independent Regulation, Infection and Immunity, vol.68, issue.11, pp.6294-6299, 2000.
DOI : 10.1128/IAI.68.11.6294-6299.2000

H. Ghalib, J. Whittle, M. Kubin, F. Hashim, A. Hassan et al., IL-12 enhances Th1-type responses in human Leishmania donovani infections, J. Immunol, vol.154, pp.4623-4629, 1995.

L. Donaghy, F. Cabillic, A. Corlu, O. Rostan, O. Toutirais et al., Immunostimulatory Properties of Dendritic Cells after Leishmania donovani Infection Using an In Vitro Model of Liver Microenvironment, PLoS Neglected Tropical Diseases, vol.21, issue.6, 2010.
DOI : 10.1371/journal.pntd.0000703.g005

URL : https://hal.archives-ouvertes.fr/hal-00665922

J. Gangneux, L. Donaghy, and M. P. , Place du foie dans la leishmaniose visc??rale, Gastroent??rologie Clinique et Biologique, vol.30, issue.8-9, pp.1027-103273378, 2006.
DOI : 10.1016/S0399-8320(06)73378-4

S. Stäger, A. J. Carter, K. Brombacher, F. Kaye, and P. , Both Interleukin-4 (IL-4) and IL-4 Receptor ?? Signaling Contribute to the Development of Hepatic Granulomas with Optimal Antileishmanial Activity, Infection and Immunity, vol.71, issue.8, pp.4804-4807, 2003.
DOI : 10.1128/IAI.71.8.4804-4807.2003

P. Marvie, M. Lisbonne, L. Helgoualc-'h, A. Rauch, M. Turlin et al., Interleukin-33 overexpression is associated with liver fibrosis in mice and humans, Journal of Cellular and Molecular Medicine, vol.190, issue.6b, pp.1726-1739, 2010.
DOI : 10.1111/j.1582-4934.2009.00801.x

URL : https://hal.archives-ouvertes.fr/hal-00660257

M. Kurowska-stolarska, A. Hueber, B. Stolarski, and I. Mcinnes, Interleukin-33: a novel mediator with a role in distinct disease pathologies, Journal of Internal Medicine, vol.107, issue.1, pp.29-35, 2011.
DOI : 10.1111/j.1365-2796.2010.02316.x

F. Liew, IL-33: a Janus cytokine: Table 1, Annals of the Rheumatic Diseases, vol.71, issue.Suppl 2, pp.101-104, 2012.
DOI : 10.1136/annrheumdis-2011-200589

M. Milovanovic, V. Volarevic, G. Radosavljevic, I. Jovanovic, N. Pejnovic et al., IL-33/ST2 axis in inflammation and immunopathology, Immunologic Research, vol.164, issue.2, pp.89-99, 2012.
DOI : 10.1007/s12026-012-8283-9

G. Palmer and C. Gabay, Interleukin-33 biology with potential insights into human diseases, Nature Reviews Rheumatology, vol.17, issue.6, pp.321-329, 2011.
DOI : 10.1038/nrrheum.2011.53

M. Arshad, C. Piquet-pellorce, L. Helgoualc-'h, A. Rauch, M. Patrat-delon et al., TRAIL but not FasL and TNF??, regulates IL-33 expression in murine hepatocytes during acute hepatitis, Hepatology, vol.31, issue.Suppl 1, pp.2353-2362, 2012.
DOI : 10.1002/hep.25893

M. Arshad, M. Rauch, L. Helgoualc-'h, A. Julia, V. Leite-de-moraes et al., NKT cells are required to induce high IL-33 expression in hepatocytes during ConA-induced acute hepatitis, European Journal of Immunology, vol.41, issue.8, pp.2341-2348, 2011.
DOI : 10.1002/eji.201041332

URL : https://hal.archives-ouvertes.fr/hal-00681990

M. Duarte and C. Corbett, Histopathological patterns of the liver involvement in visceral leishmaniasis, Revista do Instituto de Medicina Tropical de S??o Paulo, vol.29, issue.3, pp.131-136, 1987.
DOI : 10.1590/S0036-46651987000300003

R. Kakkar and R. Lee, The IL-33/ST2 pathway: therapeutic target and novel biomarker, Nature Reviews Drug Discovery, vol.348, issue.10, pp.827-840, 2008.
DOI : 10.1038/nrd2660

P. Sun, Q. Ben, S. Tu, W. Dong, X. Qi et al., Serum Interleukin-33 Levels in Patients with Gastric Cancer, Digestive Diseases and Sciences, vol.16, issue.12, pp.3596-3601, 2011.
DOI : 10.1007/s10620-011-1760-5

C. Moussion, N. Ortega, and J. Girard, The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel ???Alarmin????, PLoS ONE, vol.106, issue.10, 2008.
DOI : 10.1371/journal.pone.0003331.g006

P. Kunes, Z. Holubcova, M. Kolackova, and J. Krejsek, Interleukin-33, a Novel Member of the IL-1/IL-18 Cytokine Family, in Cardiology and Cardiac Surgery, The Thoracic and Cardiovascular Surgeon, vol.58, issue.08, pp.443-449, 2010.
DOI : 10.1055/s-0030-1250436

J. Seidelin, G. Rogler, and O. Nielsen, A role for interleukin-33 in TH2-polarized intestinal inflammation?, Mucosal Immunology, vol.157, issue.5, pp.496-502, 2011.
DOI : 10.1136/gut.2003.034165

V. Trajkovic, M. Sweet, and D. Xu, T1/ST2???an IL-1 receptor-like modulator of immune responses, Cytokine & Growth Factor Reviews, vol.15, issue.2-3, pp.87-95, 2004.
DOI : 10.1016/j.cytogfr.2004.02.004

E. Carvalho, A. Barral, J. Costa, A. Bittencourt, and P. Marsden, Clinical and immunopathological aspects of disseminated cutaneous leishmaniasis, Acta Tropica, vol.56, issue.4, pp.315-325, 1994.
DOI : 10.1016/0001-706X(94)90103-1

P. Mansueto, G. Vitale, D. Lorenzo, G. Rini, G. Mansueto et al., Immunopathology of Leishmaniasis: An Update, International Journal of Immunopathology and Pharmacology, vol.189, issue.3, pp.435-445, 2007.
DOI : 10.1177/039463200702000302

S. Saha, S. Mondal, A. Banerjee, J. Ghose, S. Bhowmick et al., Immune responses in kala-azar, Indian J. Med. Res, vol.123, pp.245-266, 2006.

K. Zwingenberger, G. Harms, C. Pedrosa, S. Omena, B. Sandkamp et al., Determinants of the immune response in visceral leishmaniasis: Evidence for predominance of endogenous interleukin 4 over interferon-?? production, Clinical Immunology and Immunopathology, vol.57, issue.2, pp.242-249, 1990.
DOI : 10.1016/0090-1229(90)90038-R

P. Kaye, M. Svensson, M. Ato, A. Maroof, R. Polley et al., The immunopathology of experimental visceral leishmaniasis, Immunological Reviews, vol.146, issue.1, pp.239-253, 2004.
DOI : 10.1128/IAI.71.1.401-410.2003

A. Stanley and C. Engwerda, Balancing immunity and pathology in visceral leishmaniasis, Immunology and Cell Biology, vol.42, issue.2, pp.138-147, 2007.
DOI : 10.1038/sj.icb7100011

O. Bacellar, C. Brodskyn, J. Guerreiro, M. Barral-netto, C. Costa et al., Interleukin-12 Restores Interferon-?? Production and Cytotoxic Responses in Visceral Leishmaniasis, Journal of Infectious Diseases, vol.173, issue.6, pp.1515-1518, 1996.
DOI : 10.1093/infdis/173.6.1515

D. Hoover, C. Nacy, and M. Meltzer, Human monocyte activation for cytotoxicity against intracellular Leishmania donovani amastigotes: Induction of microbicidal activity by Interferon-??, Cellular Immunology, vol.94, issue.2, pp.500-511, 1985.
DOI : 10.1016/0008-8749(85)90274-6

N. Reiner, W. Ng, C. Wilson, W. Mcmaster, and S. Burchett, Modulation of in vitro monocyte cytokine responses to Leishmania donovani. Interferon-gamma prevents parasite-induced inhibition of interleukin 1 production and primes monocytes to respond to Leishmania by producing both tumor necrosis factor-alpha and interleukin 1., Journal of Clinical Investigation, vol.85, issue.6, pp.1914-1924, 1990.
DOI : 10.1172/JCI114654

A. Taylor and H. Murray, Intracellular Antimicrobial Activity in the Absence of Interferon-??: Effect of Interleukin-12 in Experimental Visceral Leishmaniasis in Interferon-?? Gene-disrupted Mice, The Journal of Experimental Medicine, vol.61, issue.7, pp.1231-1239, 1997.
DOI : 10.1016/1074-7613(95)90163-9

D. Piehler, A. Grahnert, M. Eschke, T. Richter, G. Köhler et al., T1/ST2 promotes T helper 2 cell activation and polyfunctionality in bronchopulmonary mycosis, Mucosal Immunology, vol.176, issue.2, pp.405-414, 2013.
DOI : 10.1073/pnas.0607863103

F. Robert-gangneux, A. Drogoul, O. Rostan, C. Piquet-pellorce, J. Cayon et al., Invariant NKT Cells Drive Hepatic Cytokinic Microenvironment Favoring Efficient Granuloma Formation and Early Control of Leishmania donovani Infection, PLoS ONE, vol.3, issue.3, 2012.
DOI : 10.1371/journal.pone.0033413.s004

URL : https://hal.archives-ouvertes.fr/hal-00696897

A. Elshafie, E. Hlin, L. Håkansson, G. Elghazali, S. Safi et al., Activity and turnover of eosinophil and neutrophil granulocytes are altered in visceral leishmaniasis, International Journal for Parasitology, vol.41, issue.3-4, pp.463-469, 2011.
DOI : 10.1016/j.ijpara.2010.11.005

S. Mehrotra, M. Fakiola, J. Oommen, S. Jamieson, A. Mishra et al., Genetic and functional evaluation of the role of CXCR1 and CXCR2 in susceptibility to visceral leishmaniasis in north-east India, BMC Medical Genetics, vol.16, issue.9, pp.162-172, 2011.
DOI : 10.1038/nm.2209

H. Le, V. Tran, W. Kim, J. Kim, H. Cho et al., IL-33 Priming Regulates Multiple Steps of the Neutrophil-Mediated Anti-Candida albicans Response by Modulating TLR and Dectin-1 Signals, The Journal of Immunology, vol.189, issue.1, pp.287-295, 2012.
DOI : 10.4049/jimmunol.1103564

N. Sakai, H. Van-sweringen, R. Quillin, R. Schuster, J. Blanchard et al., Interleukin-33 Is hepatoprotective during liver ischemia/reperfusion in mice, Hepatology, vol.394, issue.4, pp.1468-1478, 2012.
DOI : 10.1002/hep.25768

S. Sanada, D. Hakuno, L. Higgins, E. Schreiter, A. Mckenzie et al., IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system, Journal of Clinical Investigation, vol.117, issue.6, pp.1538-1549, 2007.
DOI : 10.1172/JCI30634

Y. Homma, S. Cao, X. Shi, and X. Ma, The Th2 transcription factor c-Maf inhibits IL-12p35 gene expression in activated macrophages by targeting NF-kappaB nuclear translocation, J. Interferon Cytokine Res, vol.27, pp.799-808, 2007.

T. Murphy, M. Cleveland, P. Kulesza, J. Magram, and K. Murphy, Regulation of interleukin 12 p40 expression through an NF-kappa B half-site., Molecular and Cellular Biology, vol.15, issue.10, pp.5258-5267, 1995.
DOI : 10.1128/MCB.15.10.5258

S. Goodbourn, The regulation of beta-interferon gene expression, Semin. Cancer Biol, vol.1, pp.89-95, 1990.

Y. Ohmori, S. Fukumoto, and T. Hamilton, Two structurally distinct kappa B sequence motifs cooperatively control LPS-induced KC gene transcription in mouse macrophages, J. Immunol, vol.155, pp.3593-3600, 1995.

A. Ueda, K. Okuda, S. Ohno, A. Shirai, T. Igarashi et al., NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene, J. Immunol, vol.153, pp.2052-2063, 1994.

U. Widmer, K. Manogue, A. Cerami, and B. Sherry, Genomic cloning and promoter analysis of macrophage inflammatory protein (MIP)-2, MIP-1alpha, and MIP-1beta, members of the chemokine superfamily of proinflammatory cytokines, J. Immunol, vol.150, pp.4996-5012, 1993.

P. Maxwell, R. Gallagher, A. Seaton, C. Wilson, P. Scullin et al., HIF-1 and NF-??B-mediated upregulation of CXCR1 and CXCR2 expression promotes cell survival in hypoxic prostate cancer cells, Oncogene, vol.90, issue.52, pp.7333-7345, 2007.
DOI : 10.1038/sj.onc.1210536

D. Gregory, M. Godbout, I. Contreras, G. Forget, and M. Olivier, A novel form of NF-??B is induced byLeishmaniainfection: Involvement in macrophage gene expression, European Journal of Immunology, vol.169, issue.4, pp.1071-1081, 2008.
DOI : 10.1002/eji.200737586

V. Singh, S. Balaraman, P. Tewary, and R. Madhubala, Leishmania donovani activates nuclear transcription factor-??B in macrophages through reactive oxygen intermediates, Biochemical and Biophysical Research Communications, vol.322, issue.3, pp.1086-1095, 2004.
DOI : 10.1016/j.bbrc.2004.08.016

H. Murray, J. Stern, K. Welte, B. Rubin, S. Carriero et al., Experimental visceral leishmaniasis: production of interleukin 2 and interferon-gamma, tissue immune reaction, and response to treatment with interleukin 2 and interferon-gamma, J. Immunol, vol.138, pp.2290-2297, 1987.